Zai Lab (ZLAB) FCF Margin (2020 - 2026)

Zai Lab's (ZLAB) quarterly FCF Margin came in at 13.16% in Q1 2026, up 754156.0% year-on-year from N/an in Q1 2025, and down 262.42% quarter-over-quarter from 8.1% in Q4 2025.

Zai Lab (ZLAB) FCF Margin (2020 - 2026) Analysis & Trends

Zai Lab has disclosed FCF Margin across 7 years of filings, most recently posting 13.16% for Q1 2026.

  • FCF Margin for Q1 2026 came in at 13.16%, up 754156.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2281.12% (up 217652.0% YoY), and the FY2025 annual result was 5296.33%, up 1045552.0% from the prior year.
  • FCF Margin came in at 13.16% for Q1 2026 at Zai Lab, down from 8.1% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 24.11% in Q4 2023 to a low of 10728.5% in Q2 2024.
  • The 5-year median for FCF Margin is 66.03% (2022), against an average of 1369.38%.
  • Peak annual rise in FCF Margin reached 1069742 bps in 2025, while the deepest fall reached 1219 bps in 2025.
  • Zai Lab's FCF Margin stood at 183.28% in 2022, then soared by 113 bps to 24.11% in 2023, then dropped by 16 bps to 20.29% in 2024, then tumbled by 60 bps to 8.1% in 2025, then plunged by 262 bps to 13.16% in 2026.
  • The last three FCF Margin figures came in at 13.16% (Q1 2026), 8.1% (Q4 2025), and 30.19% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn -13.16%

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.16%
Dec 31, 2025 8.10%
Sep 30, 2025 -30.19%
Jun 30, 2025 -31.08%
Mar 31, 2025 -7,554.72%
Dec 31, 2024 20.29%
Sep 30, 2024 -27.54%
Jun 30, 2024 -10,728.50%
Dec 31, 2023 24.11%
Mar 31, 2023 -115.93%
Dec 31, 2022 -183.28%
Sep 30, 2022 -231.16%
Jun 30, 2022 -100.97%
Mar 31, 2022 -207.32%
Dec 31, 2021 -362.51%
Mar 31, 2021 -851.53%
Dec 31, 2020 -328.81%
Sep 30, 2020 -566.06%
Jun 30, 2020 -479.65%
Mar 31, 2020 -497.49%